Articles

It was once thought that after guiding the development of male sex organs in a fetus, the Y chromosome did not do much else. But over the past few years, results from multiple studies have challenged that belief. The most recent evidence comes from a new study that suggests that the Y chromosome may actually protect men from aggressive bladder cancer. Read More ›

Philadelphia, PA—Patients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety during cancer treatment, had a shorter progression-free survival than patients who did not, according to results published in Clinical Cancer Research, a journal of the American Association for Cancer Research. Read More ›

Chicago, IL—It is well documented that clinical trials thus far have for the most part excluded underserved populations, and that means the results of these trials cannot be generalized to society at large. Fortunately, the federal government and medical societies have taken aim at remedying this imbalance in accrual for clinical trials. Read More ›

October is Breast Cancer Awareness Month. The purpose of this national campaign, which encompasses a wide range of initiatives conducted by local community organizations, breast cancer advocacy organizations, and major retailers, is to educate the public about breast cancer risk factors, promote screening and prevention, support individuals diagnosed with the disease and their loved ones, and raise funds for breast cancer research. Breast Cancer Awareness Month has been on the national calendar since 1985. Read More ›

This section provides a brief overview of new cancer drugs and new indications approved by the FDA between August 9, 2023, and August 14, 2023. Read More ›

Alexandria, VA—In the Prevent Cancer Foundation’s first annual Early Detection Survey, 65% of Americans aged ≥21 years say they are not up to date with one or more routine cancer screenings. Read More ›